title: [Dipeptidyl peptidase IV in inflammatory bowel diseases (DPP IV/CD26)].
abstract: Inflammatory bowel diseases (Crohn's disease, ulcerative colitis, undetermined colitis) are a group of chronic autoimmune inflammatory diseases distinguished by recurrent inflammation of various parts of the gastrointestinal (GI) system and presenting a significant public health problem. Despite large basic and clinical research, the aetiology of these diseases and the pathogenesis of inflammation itself remain elusive. Previous studies have confirmed a causal relationship between mediators of inflammatory response and molecules involved in the regulation of their biological activity, especially proteases. The aim of this review is to summarise earlier findings on different aspects of inflammatory bowel diseases, paying particular attention to the involvement of dipeptidyl peptidase IV (CD26 molecule, DPP IV/CD26) in the etiopathogenesis of inflammatory processes in the GI tract. Animal studies of colitis have significantly contributed to the understanding and treatment of these diseases, investigations of ulcerative colitis (DSS-colitis) and Crohn's disease (TNBS-colitis) on the murine model in particular.
authors.affiliation: Zavod za kemiju i biokemiju, Medicinski fakultet Sveučilišta u Rijeci, Rijeka, Hrvatska.
authors.forename: Lara Batičić
authors.initials: LB
authors.lastname: Pučar
authors.forename: Dijana
authors.initials: D
authors.lastname: Detel
authors.forename: Jadranka
authors.initials: J
authors.lastname: Varljen
mesh_terms: D000818:Animals; D018819:Dipeptidyl Peptidase 4 / Q000502:physiology*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000201:enzymology* / Q000209:etiology; D012307:Risk Factors
chemical_list: D018819:Dipeptidyl Peptidase 4